Why did Roche pay $2B for an oncology healthcare start-up and what does it mean for oncologists?

Why did Roche pay $2B for an oncology healthcare start-up and what does it mean for oncologists?

On April 6, the Swiss pharmaceutical giant, Roche, announced that it had completed the acquisition of Flatiron Health for $1.9 billion. Based in New York City’s flatiron district, the company was started in 2012 by serial entrepreneurs Nat Turner and Zach Weinberg.

Read More